Evidence map›Paper›PMID 42555680›Full record

ArticleThe Indian journal of medical research2026

Prevalence of and factors associated with psychoactive substance use among people in prisons: A multi-centre, cross-sectional study in India.

Ravindra Rao, Preethy Kathiresan, Ashwani Kumar Mishra, Atul Ambekar, Alok Agrawal, Roshan Bhad, Amit Arya, Sanjay Kumar Munda, Sourav Khanra, Arun Kandasamy and 6 more

Abstract readMulticenter Study
In one paragraph

Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ravindra RaoNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Preethy KathiresanDepartment of Psychiatry, All India Institute of Medical Sciences, ew Delhi, India.
Ashwani Kumar MishraNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Atul AmbekarNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Alok AgrawalNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Roshan BhadNational Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
Amit AryaDepartment of Psychiatry, King George's Medical University, Lucknow, Uttar Pradesh, India.
Sanjay Kumar MundaCentre for Addiction Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.
Sourav KhanraCentre for Addiction Psychiatry, Central Institute of Psychiatry, Ranchi, Jharkhand, India.
Arun KandasamyCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
Ajeet SidanaDepartment of Psychiatry, Government Medical College and Hospital, Chandigarh, India.
Uma Shankar MolanguriInstitute of Mental Health, Hyderabad, Telangana, India.
Gojendra Singh SenjamDepartment of Psychiatry, Regional Institute of Medical Sciences, Imphal, Manipur, India.
Dhrubajyoti BhuyanDepartment of Psychiatry, Assam Medical College, Dibrugarh, Assam, India.
Kranti KadamDepartment of Psychiatry, King Edward Memorial Hospital & Seth GS Medical College, Mumbai, Maharashtra, India.
Abdul MajidDepartment of Psychiatry, SKIMS Medical College and Hospital, Srinagar, Jammu and Kashmir, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objectives Large-scale studies on the prevalence of substance use disorder among people in prisons from developing countries such as India are limited, despite a sizeable number of individuals lodged in prisons. The present study aimed to assess the prevalence of various psychoactive substance use among people in prisons in India, and to assess factors associated with psychoactive substance use in prison. Methods Seventeen prisons from 9 States representing different geographical regions of the country were selected. 7004 incarcerated people selected by systematic sampling were interviewed using a structured questionnaire. Results Majority were incarcerated for the first time (n=5372, 77%) and were under remand awaiting trial or sentencing (n=4537, 65%). The proportion of incarcerated persons with lifetime use of alcohol, cannabis, and opioids was 51% (n=3579), 20% (n=1383), and 11% (n=758), respectively. 21% (n=752) of alcohol users, 30% (n=411) of cannabis users, and 45% (n=340) of opioid users used alcohol, cannabis, and opioids respectively daily in the one month before their current imprisonment. 5.9% (n=412) used a psychoactive substance (including alcohol and illicit drugs) during their current imprisonment, most commonly, cannabis (3.9%, n=273). Multivariable regression showed that psychoactive substance use in prison was significantly associated with younger age [odds ratio (OR): 1.4, 95% confidence interval (CI): 1.1, 1.8], multiple imprisonment (OR: 1.6, 95% CI: 1.3, 2.0), cannabis use before imprisonment (OR: 5.5, 95% CI: 4.1, 7.4), and substance withdrawals inside prison (alcohol OR: 1.8, 95% CI: 1.4, 2.4, cannabis OR: 2.9, 95% CI: 2.1, 4.1, opioids OR: 3.1; 95% CI: 2.3, 4.2). Interpretations and conclusions The study documents high lifetime substance use among individuals in prisons in India and identifies various factors associated with substance use during current imprisonment.

Indexed as

PrisonersPsychotropic DrugsSubstance-Related DisordersAdultCross-Sectional StudiesFemaleHumansIndiaMalePrevalencePrisonsRisk FactorsPsychotropic DrugsImprisoned individualsIncarcerationIndiaPrisonsSubstance-related disorders

Identifiers

PMID42555680
PMCPMC13466859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.